• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血脂异常在糖尿病微血管并发症中的新作用。

The emerging role of dyslipidemia in diabetic microvascular complications.

机构信息

Department of Neurology, University of Michigan, Ann Arbor, Michigan, USA.

出版信息

Curr Opin Endocrinol Diabetes Obes. 2020 Apr;27(2):115-123. doi: 10.1097/MED.0000000000000533.

DOI:10.1097/MED.0000000000000533
PMID:32073426
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11533224/
Abstract

PURPOSE OF REVIEW

To summarize recent advancements in our understanding of the impact of dyslipidemia on microvascular complications in type 2 diabetes (T2D), with an emphasis on peripheral neuropathy and nephropathy.

RECENT FINDINGS

Mounting evidence suggests that rigorous glycemic control only mitigates certain microvascular complications in T2D patients. Particularly, well regulated blood glucose levels only marginally improve peripheral neuropathy in the T2D setting. Dyslipidemia, an abnormal lipid profile, is emerging as a key factor in peripheral neuropathy. Furthermore, although glycemic control may prevent or slow nephropathy, recent developments demonstrate that dyslipidemia can also affect kidney outcomes in normoglycemic patients. Transcriptomic, epigenomic, and lipidomic investigations, as well as integrative approaches, are shedding light on potential pathomechanisms. These molecular studies are identifying possible targets for therapeutic intervention. Complementing molecular research, lifestyle interventions are on-going to assess whether dietary choices and/or exercise, weight-loss, or surgical interventions, such as bariatric surgery, can ameliorate peripheral neuropathy and nephropathy in T2D patients.

SUMMARY

Dyslipidemia is an emerging mechanism in microvascular complications in T2D. Elucidating the molecular pathomechanisms may pinpoint potential lipid-centric treatments. Interventional studies of dietary changes, exercise, or weight-loss surgery may also positively impact these highly prevalent and morbid complications.

摘要

目的综述

总结血脂异常对 2 型糖尿病(T2D)微血管并发症影响的最新进展,重点关注周围神经病变和肾病。

最新发现

越来越多的证据表明,严格的血糖控制只能减轻 T2D 患者的某些微血管并发症。特别是,血糖控制良好仅能轻微改善 T2D 患者的周围神经病变。血脂异常,即异常的脂质谱,正成为周围神经病变的一个关键因素。此外,尽管血糖控制可能预防或延缓肾病,但最近的研究表明,血脂异常也会影响血糖正常的患者的肾脏结局。转录组学、表观基因组学和脂质组学研究以及综合方法正在揭示潜在的病理机制。这些分子研究正在确定可能的治疗干预靶点。补充分子研究,生活方式干预正在评估饮食选择和/或运动、减肥或手术干预(如减肥手术)是否可以改善 T2D 患者的周围神经病变和肾病。

总结

血脂异常是 T2D 微血管并发症的一个新出现的机制。阐明分子病理机制可能会指出潜在的以脂质为中心的治疗方法。饮食改变、运动或减肥手术的干预研究也可能对这些高度流行和病态的并发症产生积极影响。

相似文献

1
The emerging role of dyslipidemia in diabetic microvascular complications.血脂异常在糖尿病微血管并发症中的新作用。
Curr Opin Endocrinol Diabetes Obes. 2020 Apr;27(2):115-123. doi: 10.1097/MED.0000000000000533.
2
Microvascular Outcomes in Patients With Diabetes After Bariatric Surgery Versus Usual Care: A Matched Cohort Study.减肥手术后与常规护理相比糖尿病患者的微血管结局:一项匹配队列研究。
Ann Intern Med. 2018 Sep 4;169(5):300-310. doi: 10.7326/M17-2383. Epub 2018 Aug 7.
3
Fasting Glucose Variation Predicts Microvascular Risk in ACCORD and VADT.空腹血糖波动预测 ACCORD 和 VADT 中的微血管风险。
J Clin Endocrinol Metab. 2021 Mar 25;106(4):1150-1162. doi: 10.1210/clinem/dgaa941.
4
Bariatric and metabolic surgery and microvascular complications of type 2 diabetes mellitus.肥胖症与代谢手术及2型糖尿病的微血管并发症
J Bras Nefrol. 2015 Jul-Sep;37(3):399-409. doi: 10.5935/0101-2800.20150061.
5
[Diabetic dyslipidemia and microvascular complications of diabetes].[糖尿病血脂异常与糖尿病微血管并发症]
Vnitr Lek. 2018 Winter;64(1):17-24.
6
Clinical Outcomes of Metabolic Surgery: Microvascular and Macrovascular Complications.代谢手术的临床结果:微血管和大血管并发症
Diabetes Care. 2016 Jun;39(6):912-23. doi: 10.2337/dc16-0157.
7
Correlation between plasma fibrinogen levels and microvascular complications in type 2 diabetes.血浆纤维蛋白原水平与 2 型糖尿病微血管并发症的相关性。
J Pak Med Assoc. 2024 Aug;74(8):1441-1448. doi: 10.47391/JPMA.10403.
8
How to prevent the microvascular complications of type 2 diabetes beyond glucose control.如何预防 2 型糖尿病的微血管并发症,超越血糖控制。
BMJ. 2017 Jan 17;356:i6505. doi: 10.1136/bmj.i6505.
9
Diabetes Self-Management Education and Medical Nutrition Therapy: A Multisite Study Documenting the Efficacy of Registered Dietitian Nutritionist Interventions in the Management of Glycemic Control and Diabetic Dyslipidemia through Retrospective Chart Review.糖尿病自我管理教育和医学营养治疗:通过回顾性图表审查记录注册营养师干预在血糖控制和糖尿病血脂异常管理中的疗效的多地点研究文件。
J Acad Nutr Diet. 2019 Mar;119(3):449-463. doi: 10.1016/j.jand.2018.06.303. Epub 2018 Sep 13.
10
Periodontitis and Diabetes Complications: A Danish Population-Based Study.牙周炎与糖尿病并发症:一项丹麦基于人群的研究。
J Dent Res. 2024 Aug;103(9):870-877. doi: 10.1177/00220345241259954. Epub 2024 Aug 5.

引用本文的文献

1
Exploring the interplay between adipokine-mediated celastrol target genes and T cells in diabetic nephropathy: a mendelian randomization-based causal inference.探索脂肪因子介导的雷公藤红素靶基因与糖尿病肾病中T细胞之间的相互作用:基于孟德尔随机化的因果推断
Diabetol Metab Syndr. 2025 Mar 18;17(1):89. doi: 10.1186/s13098-025-01665-0.
2
The differential effects of dyslipidemia status and triglyceride-glucose index on left ventricular global function and myocardial microcirculation in diabetic individuals: a cardiac magnetic resonance study.血脂异常状态和甘油三酯-葡萄糖指数对糖尿病个体左心室整体功能和心肌微循环的差异影响:一项心脏磁共振研究。
Cardiovasc Diabetol. 2024 Sep 19;23(1):345. doi: 10.1186/s12933-024-02435-4.
3
Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate-Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factors (ENSEMBLE).研究设计和方案:评估依折麦布、非诺贝特和中等强度他汀三联治疗 2 型糖尿病合并可调节心血管危险因素患者的长期疗效和安全性的随机对照试验(ENSEMBLE)。
Endocrinol Metab (Seoul). 2024 Oct;39(5):722-731. doi: 10.3803/EnM.2024.1995. Epub 2024 Aug 22.
4
Trajectories of Remnant Cholesterol are Associated with Diabetic Foot Ulcer in Adult Patients with Type 2 Diabetes: A Retrospective Cohort Study.残余胆固醇轨迹与成年2型糖尿病患者糖尿病足溃疡相关:一项回顾性队列研究
Diabetes Metab Syndr Obes. 2024 Aug 16;17:3043-3051. doi: 10.2147/DMSO.S461330. eCollection 2024.
5
Cardiovascular health metrics and diabetic nephropathy: a nationally representative cross-sectional study.心血管健康指标与糖尿病肾病:一项全国代表性的横断面研究。
Int Urol Nephrol. 2024 Nov;56(11):3569-3584. doi: 10.1007/s11255-024-04097-3. Epub 2024 Jun 5.
6
Modulating effects of crocin on lipids and lipoproteins: Mechanisms and potential benefits.藏红花素对脂质和脂蛋白的调节作用:机制与潜在益处
Heliyon. 2024 Apr 3;10(7):e28837. doi: 10.1016/j.heliyon.2024.e28837. eCollection 2024 Apr 15.
7
A multi-centre investigation of macrovascular and non-ocular microvascular complications in children and adolescents with diabetes mellitus in southern Ghana.加纳南部儿童和青少年糖尿病患者大血管和非眼部微血管并发症的多中心研究。
Ghana Med J. 2023 Jun;57(2):87-96. doi: 10.4314/gmj.v57i2.2.
8
Correlation of HbA1c Level with Lipid Profile in Type 2 Diabetes Mellitus Patients Visiting a Primary Healthcare Center in Jeddah City, Saudi Arabia: A Retrospective Cross-Sectional Study.沙特阿拉伯吉达市一家初级医疗保健中心2型糖尿病患者糖化血红蛋白(HbA1c)水平与血脂谱的相关性:一项回顾性横断面研究
Diseases. 2023 Oct 31;11(4):154. doi: 10.3390/diseases11040154.
9
Dynamic lipidome alterations associated with human health, disease and ageing.与人类健康、疾病和衰老相关的动态脂质组变化。
Nat Metab. 2023 Sep;5(9):1578-1594. doi: 10.1038/s42255-023-00880-1. Epub 2023 Sep 11.
10
The Beneficial Effects of Curcumin on Lipids: Possible Effects on Dyslipidemia-induced Cardiovascular Complications.姜黄素对血脂的有益作用:对血脂异常引起的心血管并发症的可能影响。
Curr Med Chem. 2024;31(42):6957-6970. doi: 10.2174/0929867331666230707094644.

本文引用的文献

1
Integrated lipidomic and transcriptomic analyses identify altered nerve triglycerides in mouse models of prediabetes and type 2 diabetes.整合脂质组学和转录组学分析确定了糖尿病前期和2型糖尿病小鼠模型中神经甘油三酯的改变。
Dis Model Mech. 2020 Jan 24;13(2):dmm042101. doi: 10.1242/dmm.042101.
2
Rapid progression of type 2 diabetes and related complications in children and young people-A literature review.儿童和青少年 2 型糖尿病及其相关并发症的快速进展——文献综述。
Pediatr Diabetes. 2020 Mar;21(2):158-172. doi: 10.1111/pedi.12953. Epub 2020 Jan 10.
3
Increased lipogenesis and impaired β-oxidation predict type 2 diabetic kidney disease progression in American Indians.在美国印第安人中,脂肪生成增加和β-氧化受损可预测 2 型糖尿病肾病的进展。
JCI Insight. 2019 Nov 1;4(21):130317. doi: 10.1172/jci.insight.130317.
4
Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9 edition.2019 年全球及各区域糖尿病患病率估算值及 2030 年和 2045 年预测值:国际糖尿病联盟糖尿病地图集(第 9 版)的结果。
Diabetes Res Clin Pract. 2019 Nov;157:107843. doi: 10.1016/j.diabres.2019.107843. Epub 2019 Sep 10.
5
Effect of Early and Late Interventions with Dietary Oils on Vascular and Neural Complications in a Type 2 Diabetic Rat Model.膳食油的早期和晚期干预对 2 型糖尿病大鼠模型血管和神经并发症的影响。
J Diabetes Res. 2019 Aug 7;2019:5020465. doi: 10.1155/2019/5020465. eCollection 2019.
6
Management of diabetes complications in youth.青少年糖尿病并发症的管理。
Ther Adv Endocrinol Metab. 2019 Jul 25;10:2042018819863226. doi: 10.1177/2042018819863226. eCollection 2019.
7
Kidney Injury Molecule-1 Is Upregulated in Renal Lipotoxicity and Mediates Palmitate-Induced Tubular Cell Injury and Inflammatory Response.肾损伤分子 1 在肾脂毒性中上调,并介导棕榈酸诱导的肾小管细胞损伤和炎症反应。
Int J Mol Sci. 2019 Jul 11;20(14):3406. doi: 10.3390/ijms20143406.
8
Metabolic Changes and Diabetes Microvascular Complications 5 Years After Obesity Surgery.肥胖症手术后 5 年的代谢变化与糖尿病微血管并发症
Obes Surg. 2019 Dec;29(12):3907-3911. doi: 10.1007/s11695-019-04095-w.
9
New insights into the mechanisms of diabetic complications: role of lipids and lipid metabolism.对糖尿病并发症机制的新认识:脂质及其代谢的作用。
Diabetologia. 2019 Sep;62(9):1539-1549. doi: 10.1007/s00125-019-4959-1. Epub 2019 Jul 25.
10
Diabetic neuropathy.糖尿病性神经病。
Nat Rev Dis Primers. 2019 Jun 13;5(1):41. doi: 10.1038/s41572-019-0092-1.